Los Angeles Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $693K | Buy |
+16,043
| New | +$693K | ﹤0.01% | 761 |
|
|
2024
Q1 | – | Sell |
-9,436
| Closed | -$381K | – | 1133 |
|
|
2023
Q4 | $381K | Sell |
9,436
-5,771
| -38% | -$233K | ﹤0.01% | 947 |
|
|
2023
Q3 | $401K | Sell |
15,207
-8,152
| -35% | -$215K | ﹤0.01% | 887 |
|
|
2023
Q2 | $402K | Buy |
23,359
+2,886
| +14% | +$49.6K | ﹤0.01% | 917 |
|
|
2023
Q1 | $339K | Sell |
20,473
-1,427
| -7% | -$23.7K | ﹤0.01% | 973 |
|
|
2022
Q4 | $167K | Sell |
21,900
-2,559
| -10% | -$19.5K | ﹤0.01% | 1151 |
|
|
2022
Q3 | $243K | Buy |
24,459
+545
| +2% | +$5.42K | ﹤0.01% | 1128 |
|
|
2022
Q2 | $217K | Sell |
23,914
-9,016
| -27% | -$81.8K | ﹤0.01% | 1240 |
|
|
2022
Q1 | $334K | Buy |
32,930
+20,500
| +165% | +$208K | ﹤0.01% | 1198 |
|
|
2021
Q4 | $207K | Sell |
12,430
-135
| -1% | -$2.25K | ﹤0.01% | 1340 |
|
|
2021
Q3 | $589K | Sell |
12,565
-10
| -0.1% | -$469 | ﹤0.01% | 977 |
|
|
2021
Q2 | $767K | Sell |
12,575
-700
| -5% | -$42.7K | ﹤0.01% | 970 |
|
|
2021
Q1 | $818K | Buy |
13,275
+217
| +2% | +$13.4K | ﹤0.01% | 991 |
|
|
2020
Q4 | $929K | Buy |
13,058
+330
| +3% | +$23.5K | ﹤0.01% | 973 |
|
|
2020
Q3 | $478K | Buy |
12,728
+3,650
| +40% | +$137K | ﹤0.01% | 1095 |
|
|
2020
Q2 | $296K | Buy |
+9,078
| New | +$296K | ﹤0.01% | 1289 |
|